Clinical investigation of the efficacy and toxicity of apatinib (YN968D1) in stage III/IV non‐small cell lung cancer after second‐line chemotherapy treatment: A retrospective study...

por Zhang, Di, Zhang, Chufeng, Huang, Jiaqi, Guan, Yan, Guo, Qisen
Publicado 2018

In vitro studies of H520 cell cycle and apoptosis by anlotinib combined with radiotherapy

por Guo, Lu, Zhang, Luyao, Guan, Yan, Li, Yan, Zhang, Chufeng, Guo, Qisen
Publicado 2021

Commensal microbiota contributes to predicting the response to immune checkpoint inhibitors in non‐small‐cell lung cancer patients

por Zhang, Chufeng, Wang, Jixin, Sun, Zhongwen, Cao, Yufeng, Mu, Zhengshuai, Ji, Xuming
Publicado 2021

Hepatocyte phosphatase DUSP22 mitigates NASH-HCC progression by targeting FAK

por Ge, Chenxu, Tan, Jun, Dai, Xianling, Kuang, Qin, Zhong, Shaoyu, Lai, Lili, Yi, Chao, Sun, Yan, Luo, Jing, Zhang, Chufeng, Zhu, Liancai, Wang, Bochu, Xu, Minxuan
Publicado 2022

The E3 ubiquitin-protein ligase Trim31 alleviates non-alcoholic fatty liver disease by targeting Rhbdf2 in mouse hepatocytes

por Xu, Minxuan, Tan, Jun, Dong, Wei, Zou, Benkui, Teng, Xuepeng, Zhu, Liancai, Ge, Chenxu, Dai, Xianling, Kuang, Qin, Zhong, Shaoyu, Lai, Lili, Yi, Chao, Tang, Tingting, Zhao, Junjie, Wang, Longyan, Liu, Jin, Wei, Hao, Sun, Yan, Yang, Qiufeng, Li, Qiang, Lou, Deshuai, Hu, Linfeng, Liu, Xi, Kuang, Gang, Luo, Jing, Xiong, Mingxin, Feng, Jing, Zhang, Chufeng, Wang, Bochu
Publicado 2022